ARCUS Genome Editing

At Precision BioSciences we are using our novel ARCUS genome editing
technology to develop a new class of medicines designed to overcome and
potentially cure, hard-to-treat conditions including rare genetic diseases.

ARCUS is a novel and proprietary genome editing platform discovered and developed by scientists at Precision BioSciences. ARCUS uses sequence- specific DNA-cutting enzymes, or nucleases, to insert (knock in), remove (knockout), or repair the DNA of living cells and tissues.

Learn more about ARCUS Genome Editing ›

ARCUS Targeting of HBV

ARCUS Dual Mechanism:
Eliminates cccDNA and inactivates integrated HBV DNA.

Learn more about our approach to HBV ›

Recent News

We credit much of our successes not only to our technical know-how, but our commitment to our team and our culture.

Find your role at Precision today